Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

40.00
-4.7400-10.59%
Post-market: 40.000.00000.00%19:29 EDT
Volume:59.49K
Turnover:2.40M
Market Cap:243.94M
PE:-20.37
High:46.00
Open:46.00
Low:35.46
Close:44.74
Loading ...

MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN

Zacks
·
02 Jan

These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025

TipRanks
·
31 Dec 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks
·
26 Dec 2024

Monopar Therapeutics Prices $40 Million Offering, Private Placement

MT Newswires Live
·
20 Dec 2024

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

THOMSON REUTERS
·
20 Dec 2024

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

GlobeNewswire
·
20 Dec 2024

Monopar Therapeutics Shares Jump After First Patient Dosed in Cancer Therapy

MT Newswires Live
·
07 Dec 2024

Monopar Therapeutics Achieves Milestone in Cancer Treatment

TIPRANKS
·
06 Dec 2024

BRIEF-Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu

Reuters
·
06 Dec 2024

Monopar Therapeutics doses first patient with MNPR-101-Lu

TIPRANKS
·
06 Dec 2024

Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu

THOMSON REUTERS
·
06 Dec 2024

BUZZ-JonesTrading raises PT on Monopar Therapeutics after AstraZeneca agreement

Reuters
·
20 Nov 2024

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
·
20 Nov 2024

Monopar Therapeutics price target raised to $37 from $9 at JonesResearch

TIPRANKS
·
20 Nov 2024

Monopar Therapeutics Gains Buy Rating Following Strategic Agreement and Promising Phase III Results for Wilson’s Disease Treatment

TIPRANKS
·
20 Nov 2024

Transformative Licensing Acquisition Drives Buy Rating for Monopar Therapeutics

TIPRANKS
·
11 Nov 2024